Frontiers in Pharmacology (Mar 2022)

In vitro Suppression of SARS-CoV-2 Infection by Existing Kampo Formulas and Crude Constituent Drugs Used for Treatment of Common Cold Respiratory Symptoms

  • Masaki Kakimoto,
  • Toshihito Nomura,
  • Toshihito Nomura,
  • Tanuza Nazmul,
  • Hiroki Kitagawa,
  • Keishi Kanno,
  • Keiko Ogawa-Ochiai,
  • Keiko Ogawa-Ochiai,
  • Hiroki Ohge,
  • Masanori Ito,
  • Takemasa Sakaguchi

DOI
https://doi.org/10.3389/fphar.2022.804103
Journal volume & issue
Vol. 13

Abstract

Read online

Several traditional Japanese Kampo formulas are known to have inhibitory effects on infections with viruses that cause respiratory symptoms. Although some herbs and their components have been reported to suppress SARS-CoV-2 replication in vitro, it is difficult to compare effective Kampo formulas because of the different methods used in studies. Thus, we carried out in vitro experiments on the suppression of SARS-CoV-2 infection by Kampo formulas and crude drugs used for the common cold to compare their suppressive effects on virus infection. After infecting VeroE6/TMPRSS2 cells with SARS-CoV-2, lysates of the Kampo formulas and crude drugs were added, and after 24 h, the infectious titer in the medium was measured by the TCID50 method. Maoto was the most effective among the Kampo formulas, and Ephedrae herba was the most effective among the constituent crude drugs. However, a comparison of the suppressive effects of Ephedrae herba and Kampo formulas containing Ephedrae herba showed that the suppressive effect on virus infection did not depend on the content of Ephedrae herba. Based on the results, we believe that the use of Maoto among Kampo formulas is suitable as a countermeasure against COVID-19.

Keywords